Actinic Keratosis Treatment Market

Global Market Study on Actinic Keratosis Treatment: Demand to Surge as Preventive Care Gains Importance

Actinic Keratosis Treatment Market Segmented Topical Treatment, Surgery, Photodynamic, Topical Treatment, Procedural Modality by Therapy Which Includes 5-fluorouracil Cream, Diclofenac Gel, Imiquimod Cream, Ingenol Mebutate Gel, Chemical Peels, Cryotherapy Treatment by Clinical Ak, Subclinical Ak Disease

  • May-2022
  • PMRREP27691
  • 275 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Actinic Keratosis Treatment Market Outlook (2022 - 2028)

Actinic Keratosis Treatment Market witnessed a CAGR of 6.6% between 2013 and 2021. The global Actinic Keratosis Treatment Market is expected to grow at a rate of 7% between 2022 and 2028. In 2022, the global Actinic Keratosis Treatment Market size was US$ 5,356 million, which is projected to reach US$ 8,029.5 million by the year 2028.

Actinic Keratosis Treatment Market Size (2022)

US$ 5,356 Mn

Projected Market Value (2028)

US$ 8,029.5 Mn

Global Market Growth Rate (2022-2028)

7% CAGR

Share in parent market

16.6%

Find Out More about the Report Coverage

Companies

  • Sun Pharmaceutical Industries Ltd.
  • Biofrontera
  • Nestle SA
  • Bausch Health Companies Inc.
  • Novartis AG
  • GlaxoSmithKline plc.
  • Almirall, LLC
  • LEO Pharma Inc.
  • Cipher Pharmaceuticals Inc
  • Pierre Fabre Pharmaceuticals, Inc.
  • BioLineRX
  • Alma Lasers
  • Valeant Pharmaceuticals
  • 3M
  • Stanford Chemicals.

Actinic Keratosis Treatment Market Demand Analysis (2013-2021) v/s Market Outlook (2022-2028)

Actinic Keratosis Treatment Market is expected to witness a CAGR of 7% due to the increase in prevalence of actinic keratosis. Furthermore, increase in need for actinic keratosis treatment products, potential drugs in pipeline, and preferable use of topical therapeutics is driving the market growth.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

What is expected to keep the Hopes High for Actinic Keratosis Treatment Market?

  • Rise in the prevalence of actinic keratosis

The rising prevalence of actinic keratosis, as well as increasing awareness about treating diseases and increasing demand for minimally invasive therapies, are expected to drive the growth of the actinic keratosis treatment market. The growing awareness regarding the harmful effects of actinic keratosis is boosting the need for actinic keratosis therapy. Furthermore, awareness programs launched by government agencies and non-profit groups contribute significantly to market development. Increasing R&D initiatives are also expected to boost new medication approvals for actinic keratosis treatment. Furthermore, the increased risk of getting actinic keratosis-related skin cancer has increased detection and treatment frequencies.

actinic-keratosis-treatment-market

  • Increase in the number of drug approvals and launch of novel therapies

The Actinic Keratosis Treatment Market is expected to grow due to an increase in medication approvals and the introduction of novel medicines for the disease. New drugs for the treatment of actinic keratoses have been authorized by the US Food and Drug Administration (FDA). These drugs include topical fluorouracil, imiquimod, diclofenac, ingenol mebutate, and pharmaceutical treatment combinations. The topical medications category accounts for a sizable market share in the actinic keratosis treatment market and is expected to exhibit a similar trend during the forecast period owing to the ease of product availability, high target specificity, and lesser risk of scarring. Furthermore, potential pipeline drugs and widespread usage of combination treatment are important driving factors to the market. Another factor that is expected to drive market expansion is a rise in the adoption and commercialization of novel medications. The increased R&D efforts are likely to boost the approval of novel medications for the treatment of actinic keratosis, which will further drive the growth of the Actinic Keratosis Treatment Market.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

What restraints is the Actinic Keratosis Treatment Market subject to?

  • “Lack of skilled professionals and low penetration of treatment”

The primary challenges impeding the growth of the actinic keratosis treatment market are a lack of skilled professionals and limited treatment penetration in emerging economies. Actinic keratosis treatment requires skilled professionals and surgeons to undertake procedures like chemical peels, cryotherapy, and photodynamic therapy. However, a significant scarcity of general surgeons is expected to hinder the growth of the actinic keratosis treatment market. Furthermore, less awareness about the health problem in developing countries, as well as higher treatment costs are projected to limit market expansion. The emergence of alternative natural remedies is also expected to hamper the market growth.

Explore Persistence Market Research’s expertise in promulgation of the business !

How has Covid-19 affected the Actinic Keratosis Treatment Market?

“Drop in sales due to lockdown”

The COVID-19 pandemic had a negative impact on the global economy and did affect several industries due to travel restrictions, lockdowns, and business closures. Because of the lockdown, the supply chain for medical equipment was disrupted globally, which resulted in the drop in sales in the actinic keratosis treatment market in the year 2020. Due to strict lockdowns, many doctors shifted to telemedicine, which resulted in a significant decrease in the detection and treatment rates. The COVID-19 pandemic has had a significant impact on the Actinic Keratosis Treatment Market but the market situation has started to improve since September 2021.

Competitive Landscape

The Actinic Keratosis Treatment industry is very competitive and highly consolidated due to the presence of a few players. These players are focusing on mergers and strategic alliances as the industry is in the growth phase. Companies are making strategic decisions to launch new products to capitalize and grow their market share.

Recent Developments:

  • Sun Pharmaceutical Industries Ltd has acquired Aquinox Pharmaceuticals (Canada) Inc, for $8.2 million. Aquinox Pharma is a pharmaceutical firm that focuses on research and development.
  • 3M Completed Acquisition of Acelity, Inc. The acquisition strengthens the company's position in advanced and surgical care. Acelity is a major worldwide medical technology firm that markets enhanced care and speciality surgical applications under the KCI brand.

Actinic Keratosis Treatment Market Industry Report Scope

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2013-2021

Market Analysis

US$ Mn/Bn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Key Countries Covered

  • U.S.
  • Canada
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • Russia
  • India
  • China
  • Japan
  • UAE
  • Australia

Key Market Segments Covered

By End User

Key Companies Profiled

  • Sun Pharmaceutical Industries Ltd.
  • Biofrontera
  • Nestle SA
  • Bausch Health Companies Inc.
  • Novartis AG
  • GlaxoSmithKline plc.
  • Almirall, LLC
  • LEO Pharma Inc.
  • Cipher Pharmaceuticals Inc.
  • Pierre Fabre Pharmaceuticals, Inc.

Customization & Pricing

Available upon Request

Actinic Keratosis Treatment Market Categorization

Actinic Keratosis Treatment Market by End User

  • Hospitals
  • Private Dermatology Clinics
  • Laser Therapy Centers
  • Cancer Treatment Centers
  • Spas and Rejuvenation Centers
  • Homecare

Actinic Keratosis Treatment Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Media Release

- FAQs -

In 2022, the Actinic Keratosis Treatment Market stands at USD 5,356 million, and it is expected to reach USD 8,029.5 million by 2028 at a CAGR of 7%.

Actinic Keratosis Treatment Market exhibited a 6.6% CAGR between 2013 and 2021.

Lack of skilled professionals and low penetration of treatment in developing nations are the key restraints in the Actinic Keratosis Treatment Market.

The rising prevalence of actinic keratosis, as well as increasing awareness about treating diseases are the key factors driving the growth of the market.

Sun Pharmaceutical Industries Ltd., Biofrontera, Nestle SA, and Bausch Health Companies Inc., are among the top players in the market.

Recommendations

Cosmetic Threads Market

Global cosmetic threads market was valued at US$ 114 Mn in 2020, and is expected to witness a CAGR of around 7% during the forecast period (2020 – 2030)..

Skin Rejuvenation Market

Global skin rejuvenation market is expected to witness the highest growth to register a healthy CAGR of a bit under 9.5% & good revenue throughout the forecast.

Stromal Vascular Fraction Market

The global market CAGR estimated for the assessment period 2017-2025 is 4.2%. The market for stromal vascular fraction is currently in its nascent stage, and awaits the establishment of the safety and efficacy of SVF devices..

Global Scar Treatment Market

The Global Scar Treatment Market value is projected to exceed US$ 14,303.6 million by the year 2029 at a steady CAGR of 3.5%. .

Our Clients

Our Clients